PMC:7696151 / 108179-108600 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"4053","span":{"begin":52,"end":60},"obj":"Species"},{"id":"4054","span":{"begin":275,"end":283},"obj":"Species"},{"id":"4174","span":{"begin":66,"end":89},"obj":"Disease"},{"id":"4175","span":{"begin":160,"end":169},"obj":"Disease"},{"id":"4176","span":{"begin":382,"end":388},"obj":"Disease"},{"id":"4177","span":{"begin":390,"end":400},"obj":"Disease"},{"id":"4178","span":{"begin":402,"end":406},"obj":"Disease"},{"id":"4179","span":{"begin":412,"end":420},"obj":"Disease"}],"attributes":[{"id":"A4053","pred":"tao:has_database_id","subj":"4053","obj":"Tax:9606"},{"id":"A4054","pred":"tao:has_database_id","subj":"4054","obj":"Tax:9606"},{"id":"A4174","pred":"tao:has_database_id","subj":"4174","obj":"MESH:D007239"},{"id":"A4175","pred":"tao:has_database_id","subj":"4175","obj":"MESH:D013585"},{"id":"A4176","pred":"tao:has_database_id","subj":"4176","obj":"MESH:D009325"},{"id":"A4177","pred":"tao:has_database_id","subj":"4177","obj":"MESH:D013280"},{"id":"A4178","pred":"tao:has_database_id","subj":"4178","obj":"MESH:D005076"},{"id":"A4179","pred":"tao:has_database_id","subj":"4179","obj":"MESH:D006261"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Bouquillar, et al. (2018) [27] Multicenter study39 patients with chronic CHIKV infection 400 mg/day HCQ3 months After three months of treatment, evidence of synovitis was disappeared in 10 of 20 subjects (50%) with swollen joins while complete remission was verified in 5 patients (19.2%) In four subjects, the treatment was interrupted due to the onset of side effects such as nausea, stomatitis, rash, and headache."}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T252","span":{"begin":160,"end":169},"obj":"Phenotype"},{"id":"T253","span":{"begin":382,"end":388},"obj":"Phenotype"},{"id":"T254","span":{"begin":390,"end":400},"obj":"Phenotype"},{"id":"T255","span":{"begin":402,"end":406},"obj":"Phenotype"},{"id":"T256","span":{"begin":412,"end":420},"obj":"Phenotype"}],"attributes":[{"id":"A252","pred":"hp_id","subj":"T252","obj":"http://purl.obolibrary.org/obo/HP_0100769"},{"id":"A253","pred":"hp_id","subj":"T253","obj":"http://purl.obolibrary.org/obo/HP_0002018"},{"id":"A254","pred":"hp_id","subj":"T254","obj":"http://purl.obolibrary.org/obo/HP_0010280"},{"id":"A255","pred":"hp_id","subj":"T255","obj":"http://purl.obolibrary.org/obo/HP_0000988"},{"id":"A256","pred":"hp_id","subj":"T256","obj":"http://purl.obolibrary.org/obo/HP_0002315"}],"text":"Bouquillar, et al. (2018) [27] Multicenter study39 patients with chronic CHIKV infection 400 mg/day HCQ3 months After three months of treatment, evidence of synovitis was disappeared in 10 of 20 subjects (50%) with swollen joins while complete remission was verified in 5 patients (19.2%) In four subjects, the treatment was interrupted due to the onset of side effects such as nausea, stomatitis, rash, and headache."}

{"project":"LitCovid-sentences","denotations":[{"id":"T738","span":{"begin":0,"end":421},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Bouquillar, et al. (2018) [27] Multicenter study39 patients with chronic CHIKV infection 400 mg/day HCQ3 months After three months of treatment, evidence of synovitis was disappeared in 10 of 20 subjects (50%) with swollen joins while complete remission was verified in 5 patients (19.2%) In four subjects, the treatment was interrupted due to the onset of side effects such as nausea, stomatitis, rash, and headache."}